A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully. For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users. “If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said. Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market. “It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.” And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021. For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).

Share:
More In Business
A.I. That Helps Take Care of Your Dog
John Honchariw, CEO and founder of Companion, joined Cheddar News to discuss the first innovative device solely designed to entertain, engage and have fun with your dog all day long. "What we aspire to as a company is to be a supplement to the relationship you have with your dog," he said.
Which Sectors Are Hiring the Most New College Graduates?
Gusto, which provides cloud-based payroll benefits and HR management software, released its new graduates report with insights into the top industries and regions for this key demographic. Luke Pardue, economist at Gusto, joined Cheddar News to discuss the report's findings and dissect job prospects.
Load More